FeesSafety
Pluang+

VivoSim signs seven-figure deal with top pharma, expects 500%+ revenue growth in 2027

Market News
19 Nov 2026, 15:05 WIB
GlobeNewsWire
View Source
Bullish
VivoSim signs seven-figure deal with top pharma, expects 500%+ revenue growth in 2027

VivoSim Labs secured a seven-figure agreement with a top-10 global pharmaceutical company for its NAMkind™ liver and intestinal toxicology testing services, driving expected revenue growth beyond 500% for fiscal 2027. The deal marks a shift as the customer moves from evaluation to paid program work, with VivoSim anticipating this testing will become a regular part of the customer's preclinical workflow. The company also reported growth in both toxicology sectors in Q3 2026 and is expanding collaborations, including new efficacy testing and AI compound partnerships. This progress aligns with FDA support for non-animal testing methods, positioning VivoSim for accelerated adoption in drug safety testing.

VivoSim Labs' recent seven-figure agreement with a top-10 global pharmaceutical company provides context for the health sector's activity on Pluang as of Nov 19, 2026 19:13 WIB. For readers following health-sector stocks, 82 of 150 priced US stocks rose while 63 fell. Notable movers include SLS at USD 14.45 with a -19.50% change, Butterfly Network Inc. (BFLY) at USD 6.35 up 4.44%, and Ginkgo Bioworks Holdings Inc. (DNA) at USD 8.78 with a 4.03% increase, with DNA showing the highest buy order activity at 94%.

More News

Bath & Body Works beats earnings and revenue estimates, launches $500M buyback, raises sales outlook.

Bath & Body Works beats earnings and revenue estimates, launches $500M buyback, raises sales outlook.

Bath & Body Works reported third-quarter earnings per share of $0.26, surpassing the $0.12 estimate, and revenue of $1.58 billion, above the $1.55 billion estimate. The company also announced a new $500 million share repurchase program and raised its...

Company Fundamentals
Bullish
52 minutes ago
Pasqal integrates quantum processors natively into Slurm for easier HPC management with NVIDIA support.

Pasqal integrates quantum processors natively into Slurm for easier HPC management with NVIDIA support.

Pasqal has integrated its neutral-atom quantum processors natively into Slurm's Hierarchical Resources (HRES) system, recently expanded by NVIDIA. This allows supercomputing centers to manage quantum processing units (QPUs) alongside CPUs and GPUs mo...

Market News
Bullish
56 minutes ago
SpaceX shifts focus from satellite internet profits to rapid AI growth, trading at a high valuation.

SpaceX shifts focus from satellite internet profits to rapid AI growth, trading at a high valuation.

SpaceX currently earns most of its profits from its Starlink satellite internet service, which has 13.6 million subscribers and generated $2.37 billion in operating income last quarter. However, the company is aggressively pivoting towards artificial...

Market News
Bullish
1 hour ago
TSMC and Applied Materials poised for strong growth amid booming semiconductor demand.

TSMC and Applied Materials poised for strong growth amid booming semiconductor demand.

Despite a recent 25% drop in semiconductor stocks, TSMC and Applied Materials stand out due to their dominant market positions and growth potential. TSMC leads with a 73% share in the foundry market, benefiting from AI chip demand and planned price h...

Market News
Bullish
1 hour ago
Stock market faces sharp correction risk amid AI turmoil and rising interest rates, Buffett advises cautious investing.

Stock market faces sharp correction risk amid AI turmoil and rising interest rates, Buffett advises cautious investing.

The stock market is vulnerable to a sharp correction due to rising interest rates and uncertainty in the AI industry following Nvidia CEO Jensen Huang's departure amid scandal. Inflation pressures have led the Federal Reserve to raise rates, potentia...

Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App